Table 2.
Patient outcomes
| Incidence of CMV reactivation by recipient / donor CMV serostatus | N / total | % |
|---|---|---|
| All recipient / donor pairs | 74/315 | 23 |
| Negative / negative pairs | 0/121 | 0 |
| Positive / negative pairs | 47/89 | 53 |
| Positive / positive pairs | 24/57 | 42 |
| Negative / positive pairs | 3/48 | 6 |
| Median time to first CMV reactivation by recipient/donor CMV serostatus pairs | N | Day (range) |
| All recipient / donor pairs | 74 | 41 (24-363) |
| Negative / negative pairs | 0 | NA |
| Positive / negative pairs | 47 | 40 (24-363) |
| Positive / positive pairs | 24 | 42 (25-222) |
| Negative / positive pairs | 3 | 40 (33-56) |
| Graft-versus-host disease | N / total | |
| Number of patients with Grade II and above | 156/315 | 50 |
| Number of patients with Grade III and above | 57/315 | 18 |
| Abbreviations: CMV – cytomegalovirus, N - number | ||